GlaxoSmithKline Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
47664.08 Cr.
|
P/BV
|
28.50
|
Book Value (Rs.)
|
98.74
|
52 Week High/Low (Rs.)
|
3148/1921
|
FV/ML
|
10/1
|
P/E(X)
|
80.23
|
Bookclosure
|
07/11/2024
|
EPS (Rs.)
|
35.07
|
Div Yield (%)
|
1.14
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 1694.06 | 1694.06 | 1694.06 | 1694.06 | 1694.06 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
Total Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| | | | | |
Reserves and Surplus | 1617.24 | 1573.54 | 2493.55 | 1308.85 | 1651.20 |
Total Reserves and Surplus | 1617.24 | 1573.54 | 2493.55 | 1308.85 | 1651.20 |
Employees Stock Options | -9.01 | -1.68 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1777.64 | 1741.27 | 2662.96 | 1478.26 | 1820.60 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Other Long Term Liabilities | 6.57 | 4.14 | 9.68 | 22.31 | 28.91 |
Long Term Provisions | 247.46 | 254.80 | 262.21 | 259.50 | 261.74 |
Total Non-Current Liabilities | 254.03 | 258.94 | 271.89 | 281.81 | 290.68 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Trade Payables | 625.41 | 427.79 | 570.55 | 466.13 | 357.06 |
Other Current Liabilities | 506.02 | 480.79 | 799.90 | 613.80 | 384.22 |
Short Term Provisions | 393.52 | 417.79 | 327.98 | 274.62 | 280.67 |
Total Current Liabilities | 1524.95 | 1326.37 | 1698.43 | 1354.58 | 1021.95 |
| | | | | |
Total Capital And Liabilities | 3556.62 | 3326.58 | 4633.28 | 3114.65 | 3133.23 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 297.72 | 295.87 | 296.15 | 343.55 | 708.46 |
Intangible Assets | 23.55 | 34.09 | 34.50 | 43.36 | 49.63 |
Capital Work-In-Progress | 13.93 | 20.31 | 30.50 | 13.21 | 120.12 |
Fixed Assets | 335.20 | 350.27 | 361.15 | 400.12 | 878.21 |
Deferred Tax Assets [Net] | 146.31 | 133.55 | 113.15 | 103.13 | 110.49 |
Long Term Loans And Advances | 0.00 | 70.00 | 190.00 | 0.00 | 8.22 |
Other Non-Current Assets | 276.68 | 278.50 | 260.95 | 408.76 | 361.45 |
Total Non-Current Assets | 758.20 | 832.32 | 925.25 | 912.01 | 1358.35 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 813.22 | 518.29 | 365.59 | 0.00 | 0.00 |
Inventories | 525.05 | 459.97 | 534.70 | 546.70 | 483.03 |
Trade Receivables | 222.06 | 192.38 | 205.24 | 215.60 | 99.80 |
Cash And Cash Equivalents | 1063.22 | 1155.93 | 2484.51 | 1157.96 | 1083.20 |
OtherCurrentAssets | 174.87 | 167.70 | 118.00 | 282.37 | 108.84 |
Total Current Assets | 2798.42 | 2494.26 | 3708.03 | 2202.64 | 1774.88 |
| | | | | |
Total Assets | 3556.62 | 3326.58 | 4633.28 | 3114.65 | 3133.23 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 387.14 | 361.80 | 368.97 | 498.50 | 488.30 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 125.39 | 125.39 | 125.39 | 125.39 | 125.39 |